Navigation Links
Novel Protein, Staufen2 Important In Maintenance Of Nerve Synapses

Researchers from Max Plank Institute of Developmental Biology have uncovered some of the molecular mysteries associated with synaptic connections between the neurons, that represent the structural and functional unit of the brain. //

In simple terms, the junction between two neurons is referred to as a synapse. It serves as a gateway of communication between the same. Storage and transmission of information occurs through these specialized contact sites. This synaptic connection is of great importance in the process of learning and remembering what has been learnt. These is a parallel change in the structural and functional characteristics of the synaptic junctions during the learning process. The exact molecular mechanism behind this modification has been largely unknown until now.

Michael Kiebler and his colleagues have now identified a protein called, Staufen2, found to play a significant role in the mainatenance of synaptic junctions. A cell devoid of this protein would lose a significant proportion of the synapses. Associated impairment in other contact sites and the signalling mechanism have also been identified.

The protein is known to be invloved in the transport of mRNAs to to specific locations inside a cell. This has been found to largely dependent on the recognition of the mRNA by special RNA binding proteins and the subsequent transport to synaptic junctions. As any defect in this process (due to missing Staufen2 protein) has been found to result in structural and functional inhibition of the synapse, it is logical to assume that the protein also plays a major role in the process of learning and memory retention.

This finding has obviously led to a better understanding of the molecular mechanisms behind the ability of the brain to learn and remember. If in the future, such mechanisms can be manipulated, it could lead to a revolution. Somebody who has a poor learning capacity can be substituted with an ‘ideal brain’. This could go a long way in the treatment of disorders related to learning and memory function.


'"/>




Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2017)... Orion, Michigan (PRWEB) , ... April 29, 2017 ... ... signs of fertility and infertility. These methods observe the naturally occurring signs ... in intercourse during the most fertile time. , Natural family planning and ...
(Date:4/29/2017)... Baltimore, MD (PRWEB) , ... April 29, 2017 , ... ... noisy jobs, so what are Americans doing in their leisure time that causes hearing ... assess lifestyle habits that may be contributing to hearing loss, as well as schedule ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... with the Home Care Association of America (HCAOA). This agreement allows HCAOA members ... services, as well as discounts on Accreditation University (AU) educational resources that help ...
(Date:4/28/2017)... ... April 28, 2017 , ... Horizon Blue Cross Blue Shield ... credit rating of “A” and its outlook as “stable.” At the same time, the ... have fallen in recent years, dip below “capital adequacy” thresholds required for its strong ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio ... These lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most ... disconnect ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ABBV), ... percent (n=145/146) of chronic hepatitis C virus (HCV) ... or 6 and compensated cirrhosis (Child-Pugh A) achieved ... 12 ) with its investigational, pan-genotypic regimen of ... were seen following 12 weeks of G/P treatment ...
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Manufacturing Services Market Analysis By Service (Manufacturing, Research), By Country, ... - 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing ... 2025 Low drug registration cost in Latin American ...
(Date:4/19/2017)... 19, 2017  IRIDEX Corporation (Nasdaq: IRIX ... for the first quarter 2017 after the close of ... team will host a corresponding conference call beginning at ... Investors interested in listening to the conference call may ... or (703) 326-3030 for international callers, using conference ID: ...
Breaking Medicine Technology: